NCT02572466

Brief Summary

This study objective is to compare the high sensitive troponin-I level in end-stage renal disease patients received hemodialysis without acute cardiovascular event with healthy population. The investigators also determine the effect of hemodialysis on troponin I level as the secondary objective.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
207

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 7, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 9, 2015

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

January 29, 2016

Status Verified

January 1, 2016

Enrollment Period

9 months

First QC Date

October 7, 2015

Last Update Submit

January 27, 2016

Conditions

Keywords

high-sensitive troponin-IEnd-stage renal diseasehemodialysis

Outcome Measures

Primary Outcomes (1)

  • High Sensitive Troponin-I in ESRD group vs Control group

    ESRD group * Measure the High Sensitive Troponin-I level before the hemodialysis session Control group * Measure the High Sensitive Troponin-I as an additional test to their follow up blood check.

    10 months

Secondary Outcomes (1)

  • High Sensitive Troponin-I in pre-hemodialysis vs post-hemodialysis

    4 hours

Study Arms (2)

ESRD group

1. Aged 18 years or older. 2. was diagnosed as End-stage renal disease for more than one year. 3. Attend hemodialysis 3 times a week consistently for more than 6 months. 4. Hemodialysis with Kt/V \> 1.2 5. No urine output or is less than 500 ml per day. 6. No symptoms of myocardial infarction Or were hospitalized with the similar diagnosis during the two weeks.

Other: Hemodialysis

Control group

1. Aged 18 years or older. 2. without kidney disease (eGFR \> 60 ml/min/1.73m2)

Interventions

ESRD group received long-term hemodialysis

ESRD group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ESRD group End-stage renal disease patients receiving regular hemodialysis at King Chulalongkorn memorial hospital, Bhumirajanagarindra kidney institute hospital. Control group Patients who come to OPD at King Chulalongkorn memorial hospital for their follow up blood check.

You may qualify if:

  • Aged 18 years or more.
  • was diagnosed as End-stage renal disease for more than one year.
  • Attend hemodialysis 3 times a week consistently for more than 6 months.
  • Hemodialysis with Kt/V \> 1.2
  • No urine output or is less than 500 ml per day.
  • No symptoms of myocardial infarction Or were hospitalized with the similar diagnosis during the two weeks.

You may not qualify if:

  • Could not complete hemodialysis, or Kt / V \<1.2
  • Has symptoms of myocardial infarction while receiving dialysis
  • Has the abnormal symptom (fever, chill, low BP) While receiving dialys

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Chulalongkorn Memorial Hospital

Bangkok, Bangkok, 10330, Thailand

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood sample

MeSH Terms

Conditions

Kidney Failure, Chronic

Interventions

Renal Dialysis

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Renal Replacement TherapyTherapeuticsSorption Detoxification

Study Officials

  • Khajohn Tiranathanagul, MD

    Chulalongkorn University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 7, 2015

First Posted

October 9, 2015

Study Start

February 1, 2015

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

January 29, 2016

Record last verified: 2016-01

Data Sharing

IPD Sharing
Will not share

Locations